Biogen's impressive Tecfidera launch hits supply snags
Posted: Wed Jun 19, 2013 11:18 pm
Biogen's impressive Tecfidera launch hits reimbursement, supply snags
No question, Biogen Idec's new multiple sclerosis pill charged out of the gate. Tecfidera is selling so well that it's expected to break the blockbuster barrier by next year. But the launch has hit a few bumps, The Wall Street Journal reports, putting CEO George Scangos under pressure to smooth Tecfidera's path..... Read More - http://www.ms-uk.org/index.cfm/BG12
No question, Biogen Idec's new multiple sclerosis pill charged out of the gate. Tecfidera is selling so well that it's expected to break the blockbuster barrier by next year. But the launch has hit a few bumps, The Wall Street Journal reports, putting CEO George Scangos under pressure to smooth Tecfidera's path..... Read More - http://www.ms-uk.org/index.cfm/BG12